Search Results 811-820 of 37978 for Two-phase

1. A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Depemokimab in Adults With Hypereosinophilic Syndrome (HES) - Mayo Clinic

   Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

2. Safety and Efficacy of Simtuzumab (GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH) - Mayo Clinic

   Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

3. Nasopharyngeal Carcinoma Clinical Trials - Mayo Clinic Research

   ... Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA Rochester, MN. There are two study questions we are asking in this randomized phase II/III trial based on ...

4. Reduced Dose Hypofractionated Radiotherapy For Indolent Non-hodgkin Lymphoma - Mayo Clinic

   The purpose of thisstudy is to evaluate reduction of radiotherapy dose for patients with indolent NHL by conducting a prospective randomized phase 2 study ...

5. ADG126 In Combination With Pembrolizumab In Patients With Advanced/Metastatic Solid Tumors - Mayo Clinic

   This is a Phase 1b/2, open-label, dose escalation study to evaluate the safety, tolerability, PK, and immunogenicity of ADG126-pembrolizumab combination ...

6. A Phase Ib Study Of Cobimetinib Administered In Combination With Niraparib, With or Without Atezolizumab, To Patients With Advanced Platinum-Sensitive Ovarian Cancer - Mayo Clinic

   About this study. This is a Phase Ib, open-label, randomized, multicenter, two-arm study designed to assess the safety, efficacy, and pharmacokinetics of ...

7. Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma - Mayo Clinic

   This is a global, multi-center, Phase 3 study that is randomized 2:1, controlled, and open label to evaluate PDS0101 (Versamune + HPVMix) in combination with ...

8. Kidney transplant - Mayo Clinic

   This can raise blood pressure and result in kidney failure, also known as end-stage renal disease. End-stage renal disease happens when the kidneys have lost ...

9. Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) - Mayo Clinic

   SCORE2 is a multicenter, prospective, randomized, phase III clinical trial in which all participants enrolled will be followed for 12 months. SCORE2 is designed ...

10. A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection - Mayo Clinic

    Additionally patients with hematologic malignancies will be evaluated on a treatment schedule of five days in a row with two weeks off. Participation ...